Chinese Journal of Organic Chemistry >
Synthesis and Antitumor Activities of Novel Organic Sulfur (Selenium) Tegafur Derivatives
Received date: 2020-12-28
Revised date: 2021-03-30
Online published: 2021-04-16
Supported by
National Natural Science Foundation of China(21802093); Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi Province(2019L0408); PhD Start-up Foundation of Shanxi Medical University(03201501)
Tegafur, as a raw material, reacted with chloroalkyl alcohols to give the intermediateN-hydroxyalkyl tegafur, then which reacted withp-toluenesulfonyl chloride to obtain tegafluoroalkyl sulfonate. A series of novel aryl (N3-tegafluoroalkyl) thio- and seleno-ether derivatives were efficiently synthesized by the reaction of tegafluoroalkyl sulfonate with diaryl disulfides or diselenides under binuclear titanium(IV) salophen perfluorobutanesulfonate/zinc catalytic system. Their structures of the target products were confirmed by1H NMR,13C NMR and HRMS. Their antitumor activities were evaluated by colorectal carcinoma HCT116 cells and gastric carcinoma SGC-7901 cells. The preliminary bioassay results showed that most target compounds had more antitumor activities than tegafur. Moreover, HCT116 cells staining experiments (DAPI) and quantitative determination by flow cytometry indicated that the growth inhibition was associated with the induction of apoptosis. In addition, organic sulfur (selenium) tegafur derivatives had lower toxicity than tegafur on human embryonic kidney HEK 293 cells.
Ningbo Li , Li Xu , Rong Ma , Qi Fan , Bo Li , Jie Qiao , Rui Guo , Xinhua Xu . Synthesis and Antitumor Activities of Novel Organic Sulfur (Selenium) Tegafur Derivatives[J]. Chinese Journal of Organic Chemistry, 2021 , 41(7) : 2723 -2734 . DOI: 10.6023/cjoc202012047
| [1] | Tsuboi, M.; Hamada, C.; Kato, H.; Ohta, M. Chemotherapy 2017, 62,357. |
| [2] | Ranieri, G.; Marech, I.; Porcelli, M. Giotta, F.; Palmiotti, G.; Laricchia, G.; Fazio, V.; Gadaleta,C. D. Oncotarget 2018, 9,8197. |
| [3] | Longleyd, B.; Harkin,D. P.; Johnston,P. G. Nat. Rev. Cancer 2003, 3,330. |
| [4] | Broto, M.; Mccabe, R.; Galve, R.; Marco,M. P. Analyst 2017, 142,2404. |
| [5] | Arias,J. L.; Sáez-Fernández, E.; López-Viota, M.; Biedma-Ortiz,R. A.; Ruiz,M. A. Med. Chem. 2012, 8,516. |
| [6] | Boisdron-celle, M.; Capitain, O.; Faroux, R.; Borg, C.; Metges,J. P.; Galais,M. P.; Kaassis, M.; Bennouna, J.; Bouhier-leporrier, O.; Francois, E.; Baumgaertner, I.; Guerin-Meyer, V.; Cojocarasu, O.; Roemer-Becuwe, C.; Stampfli, C.; Rosenfeld, L.; Lecompte, T.; Berger, V.; Morel, A.; Gamelin, E. Semin. Oncol. 2017, 44,13. |
| [7] | Zhang,Y. -X.; Dai,G. -F.; Wang, L.; Tao,J. -C. Bioorg. Med. Chem. Lett. 2007, 17,1613. |
| [8] | Tian,Z. Y.; Xie,S. Q.; Zhao, J.; Gao,W. -Y.; Wang,C. J. J. Henan Univ. 2008, 28,469 (in Chinese). |
| [8] | ( 田智勇, 谢松强, 赵瑾, 高文远, 王超杰, 河南大学学报, 2008, 28,469.) |
| [9] | Xiao,K. Y.; Dai, Y. Shi,W. Q.; Li,J. Z.; Li, Y.; Yin,S. F. Chin. J. Org. Chem. 2012, 32,169 (in Chinese). |
| [9] | ( 肖克毅, 戴亚, 石万棋, 李剑忠, 李颖, 尹述凡, 有机化学, 2012, 32,169.) |
| [10] | Liu,W. Q.; Tao,L. M.; Zang,Z. L.; Li,Y. H.; Xu,X. H. Chin. J. Synth. Chem. 2009, 17,64 (in Chinese). |
| [10] | ( 刘文奇, 陶李明, 臧中林, 李银辉, 许新华, 合成化学, 2009, 17,64.) |
| [11] | Qin,S. H.; Liu,A. Q.; Yu,S. H.; Wang,F. L. Chin. Pharmacol. Bull. 2013, 29,145 (in Chinese). |
| [11] | ( 秦三海, 刘爱芹, 于胜海, 王凤玲, 中国药理学通报, 2013, 29,145.) |
| [12] | Liu,Y. M.; Lee,H. Y.; Lai,M. J.; Pan,S. L.; Huang,H. L.; Kuo,F. C.; Chen,M. C.; Liou,J. P. Org. Biomol. Chem. 2015, 13,10226. |
| [13] | Kasprzak, A.; Koszytkowska-Stawińska, M.; Nowicka,A. M.; Buchowicz, W.; Poplawska, M. J. Org. Chem. 2019, 84,15900. |
| [14] | Rich,T. A.; Shepard,R. C.; Mosley,S. T. J. Clin. Oncol. 2004, 22,2214. |
| [15] | Wu,L. Q.; Yang,X. J.; Peng,Q. J. Sun,G. F. Eur. J. Med. Chem. 2017, 127,599. |
| [16] | Liu,W. Q.; Yin,X. H.; Zang,Z. L.; Yu,X. F.; Tao,L. M.; Li,Y. J. Xu,X. H. Chin. J. Org. Chem. 2009, 29,2021 (in Chinese). |
| [16] | ( 刘文奇, 尹显洪, 臧中林, 余晓芬, 陶李明, 李言杰, 许新华, 有机化学, 2009, 29,2021.) |
| [17] | He,W. B.; Gao,L. Q.; Chen,X. J.; Wu,Z. L.; Huang, Y.; Cao, Z.; Xu,X. H. He,W. -M. Chin. Chem. Lett. 2020, 31,1895. |
| [18] | Wu, Y.; Lin,Y. -W.; He,W. -M. Chin. Chem. Lett. 2020, 31,2999. |
| [19] | Wu, C.; Xiao,H. J.; Wang,S. W.; Tang,M. S.; Tang,Z. L.; Xia, W.; Li,W. F.; Cao, Z.; He,W. -M. ACS Sustainable Chem. Eng. 2019, 7,2169. |
| [20] | Madhunapantula,S. V.; Desai, D.; Sharma, A.; Huh,S. J.; Amin, S.; Robertson,G. P. Mol. Cancer Ther. 2008, 7,1297. |
| [21] | Sun,C. L.; Sun,X. N.; Pu,Y. X.; Li,C. Y.; Sun,L. J.; Wang, J.; Li,Y. Z. Chin. J. Org. Chem. 2017, 37,440 (in Chinese). |
| [21] | ( 孙成路, 孙晓娜, 蒲雨昕, 李传银, 孙丽杰, 王静, 李益政, 有机化学, 2017, 37,440.) |
| [22] | Wang,L. X.; Li,N. B.; Wang,H. J.; Liu, W.; Diao,H. P.; Xu,X. H. Chin. J. Org. Chem. 2019, 39,1802 (in Chinese). |
| [22] | ( 王灵晓, 李宁波, 王浩江, 刘文, 刁海鹏, 许新华, 有机化学, 2019, 39,1802.) |
| [23] | Chen,J. -Y.; Zhong,C. -T.; Gui,Q. -W.; Zhou,Y. -M.; Fang,Y. -Y.; Liu,K. -J.; Lin,Y. -W.; Cao, Z.; He,W. -M. Chin. Chem. Lett. 2021, 32,475. |
| [24] | Zang,Z. L.; Liu,S. Q.; Chen, X.; Li,Y. J.; Zhou, B.; Xu,X. H. Acta Pham. Sin. 2006, 41,1184 (in Chinese). |
| [24] | ( 臧中林, 刘少琼, 陈雄, 李言杰, 周冰, 许新华, 药学学报 2006, 41,1184.) |
| [25] | Deng,X. H.; Xia, X.; Shao,L. L.; Zang,Z. L.; Li,Y. J.; Xu,X. H. Chin. J. Synth. Chem. 2008, 16,285 (in Chinese). |
| [25] | ( 邓新华, 夏湘, 邵玲玲, 臧中林, 李言杰, 许新华, 合成化学, 2008, 16,282.) |
| [26] | Wang,L. X.; Qiao, J.; Wei,J. C.; Liang,Z. W.; Xu,X. H.; Li,N. B. Tetrahedron 2020, 76,130750. |
| [27] | Yu,A. H.; Xu,X. H. Chem. Reagents 2020, 42,1370 (in Chinese). |
| [27] | ( 喻爱和, 许新华, 化学试剂 2020, 42,1370.) |
/
| 〈 |
|
〉 |
